Marshall Posner, MD Email Marshall Posner
- PROFESSOR | Medicine, Hematology and Medical Oncology
- PROFESSOR | Otolaryngology
- Cancer (Oncology)
- Hospital Affiliation
- The Mount Sinai Hospital
- Ruttenberg Treatment Center 212-241-6756 212-241-6756
Book an Appointment - Marshall Posner, MD
Dr. Posner is Professor of Medicine, Director of Head and Neck Medical Oncology, Associate Director of the Center for Personalized Cancer Therapeutics, and Co-Leader of the Cancer Clinical Investigation Program for The Tisch Cancer Institute. Dr. Posner has been engaged in clinical and translational research in cancers of the head and neck, HIV, and immunity for more than 40 years. He develops therapies to optimize treatment and advance early diagnosis and screening; he developed the TPF chemotherapy regimen for induction chemotherapy in head and neck cancer and curative rituximab therapy for Pemphigus Vulgaris. Dr. Posner’s current research is in the area of virally caused head and neck cancers. He is also investigating models that translate genetic findings into therapeutic treatment. Dr. Posner has served on numerous NCI study sections and review committees. He has authored over 250 peer reviewed clinical, laboratory and translational scientific publications covering cancer therapeutics, monoclonal antibodies and immunology, autoimmune disease, and infectious diseases.
In the News:
Dr. Posner discusses HPV-related oral cancer in the New York Times.
Dr. Posner discusses the warning signs of oral cancer and what to watch out for on the Katie Couric show.
The ASCO Post features Dr. Posner discussing "Challenges, Progress, and Future Directions in Head and Neck Cancer" (March 1, 2012)
Dr. Marshall Posner discusses the link between HPV and oropharyngeal cancers in The Daily News feature The Daily Check Up.
American Board of Internal Medicine
- Adenoid Cystic Carcinoma (ACC)
- Head and Neck Cancers
- Merkel Cell Tumors
- Nasal Cancer
- Nasal Cavity Cancer
- Nasopharyngeal Cancer (NPC)
- Oral Cavity Cancer
- Photodynamic Therapy
- Salivary Gland Tumors
- Sinus Cancer
- Squamous Cell Carcinoma
- Throat Cancer
- Thyroid Cancer
- Tonsil Cancer
AIDS/HIV, Anti-Tumor Therapy, Cellular Immunity, Immunology, Tumorigenesis, Viruses and Virology
MD, Tufts University School of Medicine
Residency, Internal Medicine
Boston City Hospital
Fellowship, Medical Oncology
Dana Farber Cancer Institute
Ninth Warton Visiting Professor, Prince Margaret Hospital
Tisch Award for Clinical Research, Dana-Farber Cancer Institute
Alpha Omega Alpha, Medical Honor Society
HPV and Human Oropharyngeal Cancer
Translational studies to understand the biology and immunology of HPV related oropharyngeal cancer in order to inform therapeutic and preventative therapies in this disease.
Clinical Studies in Head and Neck Cancer
Development of curative therapeutics for patients with HPV positive and negative head and neck cancer, through clinical trials, drug development and translational studies using conventional chemotherapy, novel biotherapeutics vaccines and gene therapies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Posner during 2018 and/or 2019. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Merck & Co., Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Aridis Pharmaceuticals
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.